Vedecký časopis - archív

64 2025

Journal of Food and Nutrition Research
Súhrny čísla 1 / 2025

Jiang, Y. – Sun, Q. – Xiao, P. – Hao, Y. – Zhang, T. – Chu, Z.
Residues and risk exposure assessment of 6-benzylaminopurine for bean sprouts in Shandong, China
Journal of Food and Nutrition Research, 64, 2025, č. 1, s. 30-37

Zunhua Chu, Shandong Center for Disease Control and Prevention, Shandong Academy of Preventive Medicine, Shandong First Medical University School of Public Health, Jingshi Road 16992, 250014 Ji’nan, China. E-mail: shipinyuyingyang@163.com
Qing Sun, Children’s Hospital Affiliated to Shandong University, Jingshi Road 23976, 250022 Ji’nan, China. E-mail: cyansq@163.com

Original article
Received 23 May 2024; 1st revised 6 August 2024; accepted 8 October 2024; published online 23 January 2025.

DOI: https://doi.org/10.64122/ZUQT3385

Súhrn: 6-Benzylaminopurine (6-BAP) is an important ingredient in production of “toxic bean sprouts”. In order to assess health risk from 6-BAP residue in bean sprouts on a large sample size and wide sample range among large survey population, 6-BAP was detected in 149 out of 1494 bean sprouts samples collected in 2016–2020 in Shandong Province of China. High performance liquid chromatography-tandem mass spectrometry was used for analysis. Those 10.0 % samples contained 6-BAP residue above the maximum residue limit (MRL) and the average level was 0.007 mg·kg-1. Hazard quotient (HQ) of 6-BAP was 0.0 % for the general population and 0.2 % for consumers. The daily exposure of 6-BAP was accounted for 0.0 % of the the acceptable daily intake (ADI) and the estimated daily intake (EDI) of all subjects surveyed was below ADI. From the perspective of public health, the occurrence of 6-BAP residue in bean sprouts could not pose a serious health risk problem. Strict regulations on the management of 6-BAP residue in bean sprouts and human health risk assessment should be recommended.

Kľúčové slová: risk exposure assessment; plant growth regulator; acceptable daily intake; chronic intake risk assessment; public health

Na stiahnutie:
  jfnr-2025-1-pp030-037-jiang.pdf (PDF, 335.76 Kb, 554x)